Literature DB >> 32005967

Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.

Sankari Nagarajan1, Shalini V Rao1,2, Joseph Sutton1, Danya Cheeseman1, Shanade Dunn3, Evangelia K Papachristou1, Jose-Enrique Gonzalez Prada1, Dominique-Laurent Couturier1, Sanjeev Kumar1, Kamal Kishore1, Chandra Sekhar Reddy Chilamakuri1, Silvia-Elena Glont1, Emily Archer Goode1, Cara Brodie1, Naomi Guppy4, Rachael Natrajan4, Alejandra Bruna1, Carlos Caldas1, Alasdair Russell1, Rasmus Siersbæk1, Kosuke Yusa3,5, Igor Chernukhin1, Jason S Carroll6.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32005967     DOI: 10.1038/s41588-020-0582-9

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  2 in total

1.  MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer.

Authors:  Lin-Lin Zhang; Qi Li; Dian-Sheng Zhong; Wei-Jian Zhang; Xiao-Jie Sun; Yu Zhu
Journal:  Front Cell Dev Biol       Date:  2021-08-02

2.  A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.

Authors:  Yosi Gilad; Yossi Eliaz; Yang Yu; Adam M Dean; San Jung Han; Li Qin; Bert W O'Malley; David M Lonard
Journal:  Commun Biol       Date:  2021-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.